ASCP Corner

ASCP Corner

Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 2

November 15, 2009

ASCP Corner

Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 1

October 15, 2009

ASCP Corner

Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 2

September 15, 2009

ASCP Corner

Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 1

August 15, 2009

ASCP Corner

Adding Lithium or Anticonvulsants to Antipsychotics for the Treatment of Schizophrenia: Useful Strategy or Exercise in Futility?

June 18, 2009

ASCP Corner

Second-Generation Antipsychotic-Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need

May 13, 2009

ASCP Corner

All Antipsychotics Are Equal, but Some Are More Equal Than Others

March 16, 2009

ASCP Corner

Breastfeeding and Antidepressants: Clinical Dilemmas and Expert Perspectives

February 16, 2009

ASCP Corner

Why Aren’t MAOIs Used More Often?

January 15, 2009

ASCP Corner

Is the Problem of a High Placebo Response Unique to Antidepressant Trials?

December 31, 2008

ASCP Corner

Qualifications for Recertification: An Important but Evolving Set of Standards

November 30, 2008

ASCP Corner

The Search for Knowledge: Developing the American Psychiatric Association’s Practice Guideline for Major Depressive Disorder

October 31, 2008